drugset / Trial / NCT03082092

Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery

NCT03082092

Phase 4 Completed 60 enrolled Queen Elizabeth Hospital, Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Osteoarthritis of the knee is a common and important condition in our society. Despite various anesthetic methods and pain medications, pain after operation still remains as a challenge. Steroids plays a role in decreasing the inflammatory reaction and stress response from surgery. This study is to evaluate the use of an additional steroid injection, on top of usual pain killers and anesthesia, on the effect of pain control and recovery after total knee replacement. 50 subjects will be recruited, half of them will be randomized to receive a single dose of steroid injection before operation while the other half will receive a placebo. All the doctors, patients and physiotherapists are not aware of the allocation. Apart from the steroid or placebo injection, all the other treatment (eg: surgery, medications, rehabilitation protocol etc) will be the same. Doctors and physiotherapists will assess the subjects at 24, 30, 48 hours after surgery and upon discharge for their pain relief and recovery. Any complications will also be documented.

Timeline

Start
2017-06-01
Primary completion
2019-06-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 125 mg Intravenous

Indications